SABA prescriptions and asthma management practices in patients treated by specialists in Taiwan: Results from the SABINA III study

Shen, Sheng-YehSheng-YehShenChen, Chang-WenChang-WenChenLiu, Tu-ChenTu-ChenLiuWang, Cheng-YiCheng-YiWangChiu, Ming-HuangMing-HuangChiuChen, Yi-JenYi-JenChenLan, Chou-ChinChou-ChinLanShieh, Jiunn-MinJiunn-MinShiehLin, Chia-MoChia-MoLinWu, Shao-HaoShao-HaoWuHAO-CHIEN WANGYang, LalaLalaYangBeekman, Maarten JhiMaarten JhiBeekman2022-11-012022-11-012022-06-160929-6646https://scholars.lib.ntu.edu.tw/handle/123456789/624346Limited data exist on asthma medication patterns in Taiwan. The objectives of the SABINA III cross-sectional study in Taiwan were thus, to describe patient demographics and clinical features and estimate short-acting β2-agonist (SABA) and inhaled corticosteroids (ICS) prescriptions per patient.enAsthma; Observational study; Prescriptions[SDGs]SDG3SABA prescriptions and asthma management practices in patients treated by specialists in Taiwan: Results from the SABINA III studyjournal article10.1016/j.jfma.2022.05.014357186402-s2.0-85132505803https://api.elsevier.com/content/abstract/scopus_id/85132505803